The results of the present study show that an increase in CD4+ but not CD8+ T-lymphocyte infiltrate, as assessed by immunohistochemistry, was associated with poor cancer-specific survival, independent of grade, in patients undergoing potentially curative surgery for renal clear-cell cancer. Here, CD8A is linked to cancer.